XORTX Therapeutics Boosts Board With Biotech Pro

TipRanksApr 8 20:08

XORTX Therapeutics Appoints Industry Leader to Board

TipRanksApr 8 19:57

XORTX Announces Participation in Spring 2024 Investor Conferences

CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a late-stage clinical pharmaceutical company

GlobeNewswireApr 8 19:00

Xortx Therapeutics Reports Stable Finances

TipRanksApr 4 18:57

XORTX Announces New Clinical Advisory Board Member

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a biopharmaceutical company focused on developing

GlobeNewswireMar 27 17:00

XORTX: A Year of Milestones and Strategic Advancements as It Readies for a Registration Clinical Trial

Yahoo FinanceMar 19 21:30